Trial · NCT07906353
Routine Magnesium Testing and Supplementation in Acute Heart Failure (MAG-HF)
NCT07906353, Not applicable, Not yet recruiting, University of Alberta
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Routine Magnesium Testing and Supplementation in Acute Heart Failure (MAG-HF). Trials, record NCT07906353. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07906353
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Routine Magnesium Testing and Supplementation in Acute Heart Failure (MAG-HF)
- NCT number
- NCT07906353
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 260 participants, estimated
- Lead sponsor
- University of Alberta
- Conditions
- Acute Heart Failure (AHF)
- Interventions
- No Routine Magnesium Testing or Supplementation, Routine Magnesium Testing and Supplementation
- First posted
- 2026-10-30
- Last updated
- 2026-11-09
Source ClinicalTrials.gov
Registered outcomes14
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Feasibility of trial conduct | Up to 30 days | Feasibility will be assessed by recruitment rate, consent rate, intervention fidelity, and completeness of follow-up and outcome ascertainment at 30 days. |
| Secondary | Recruitment Rate | Up to 24 months (recruitment period) | Number of participants enrolled per site per month. |
| Secondary | Consent Rate | Up to 30 days | Proportion of eligible patients who provide consent. |
| Secondary | Intervention Fidelity | During index hospitalization | Adherence to assigned strategy and separation between randomized groups. |
| Secondary | Completeness of Follow-up | Up to 30 days | Proportion of participants with complete follow-up and outcome ascertainment. |
| Other | All-Cause Mortality | Up to 30 days | All-cause death following randomization. |
| Other | All-Cause Hospital Readmission | Up to 30 days | Hospital readmission for any cause following discharge from the index hospitalization. |
| Other | Heart Failure Readmission | Up to 30 days | Hospital readmission due to heart failure following discharge from the index hospitalization. |
| Other | Clinically Significant Arrhythmia | Up to 30 days | Incident new or worsened clinically significant supraventricular or ventricular arrhythmia during the index hospitalization. |
| Other | Symptomatic Hypotension | During index hospitalization | Occurrence of symptomatic hypotension during the index hospitalization. |
1 to 10 of 14Source ClinicalTrials.gov
See all 14 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07906353
GET https://conductscience.org/api/trials/v1/NCT07906353/registered